Jan Holmgren

Institute for Biomedicine — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

98h-index33.2kcitations590works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Escherichia coli research studies(229), Vibrio bacteria research studies(198), Viral gastroenteritis research and epidemiology(82), Influenza Virus Research Studies(62), Immunotherapy and Immune Responses(59)

Publications588 total

Heterologous prime-boost immunization combining parenteral and mucosal routes with different adjuvants mounts long-lived CD4+ T cell responses in lungs
Frontiers in Immunology·2025· 1 citedOpen Access
Potential for a Combined Oral Inactivated Whole-Cell Vaccine Against ETEC and Shigella: Preclinical Studies Supporting Feasibility
Vaccines·2025· 1 citedOpen Access
A double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority & lot to lot consistency of single component oral cholera vaccine BBV131 (Hillchol®) in comparison to Shanchol™
Vaccine·2025· 1 citedOpen Access
Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
Vaccines·2025· 2 citedOpen Access
Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study
The Lancet Microbe·2025· 1 citedOpen Access
Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic <i>Escherichia coli</i> diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa
Journal of Travel Medicine·2023· 33 citedOpen Access
A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine
Vaccine·2023· 5 citedOpen Access
Memorial for Nils Lycke
Mucosal Immunology·2023Open Access
Vaccines Against Diarrhea Caused by Noncholera Bacteria
Elsevier eBooks·2023
Cholera Vaccines
Elsevier eBooks·2023· 1 cited
Contributors
Elsevier eBooks·2023
S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice
Mucosal Immunology·2022· 10 citedOpen Access
Evaluating improved inactivated oral cholera vaccines for use in ending endemic cholera by 2030: opportunities and challenges
The Lancet Infectious Diseases·2022· 5 cited
S100A4 exerts robust mucosal adjuvant activity for co-administered antigens in mice
2022· 3 citedOpen Access
Modern History of Cholera Vaccines and the Pivotal Role of icddr,b
The Journal of Infectious Diseases·2021· 23 citedOpen Access
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh
Vaccine·2021· 13 citedOpen Access
An Update on Cholera Immunity and Current and Future Cholera Vaccines
Tropical Medicine and Infectious Disease·2021· 39 citedOpen Access
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
Vascular Pharmacology·2021· 7 citedOpen Access
Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine
Vaccine·2020· 16 citedOpen Access
Immunomodulation at Mucosal Surfaces: Prospects for the Development of Antiinfectious and Antiinflammatory Vaccines
2020
page 1 of 30Next →

Frequent Co-authors

Cécil Czerkinsky(14), Ann‐Mari Svennerholm(8), John D. Clemens(7), Nils Lycke(6), G. Balakrish Nair(5), M. R. Khan(5), A M Svennerholm(5), Michael Lebens(4), Swapan Kumar Niyogi(4), Lars Svennerholm(4), Mohammad Yunus(4), Mohammad Ali(4), David A. Sack(4), Jiabin Sun(4), Marianne Lindblad(4), Joaquı́n Sánchez(4), Marianne Jertborn(4), Dipika Sur(3), Anna Lena Lopez(3), Suman Kanungo(3)